• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环状 RNA_0000190 及其靶 microRNA-767-5p 失调,与多发性骨髓瘤患者的风险分层及预后相关。

Circular RNA_0000190 and its target microRNA-767-5p are dysregulated, and they are related to risk stratification as well as prognosis in multiple myeloma patients.

机构信息

Department of Hematology, The First People's Hospital of Jingmen, No. 67 Xiangshan Avenue, Jingmen, 448000, People's Republic of, China.

Department of Cardiovascular Medicine, The First People's Hospital of Jingmen, Jingmen, 448000, China.

出版信息

Ir J Med Sci. 2022 Apr;191(2):671-679. doi: 10.1007/s11845-021-02586-3. Epub 2021 Apr 16.

DOI:10.1007/s11845-021-02586-3
PMID:33864191
Abstract

BACKGROUND

This study aimed to explore the correlation between circular RNA_0000190 (circ_0000190) and microRNA-767-5p (miR-767-5p), and their correlations with biochemical indices, risk stratification, treatment response, and survival in multiple myeloma (MM) patients.

METHODS

Bone marrow (BM) plasma cells of 86 MM patients (during standard diagnostic procedures) and 30 healthy donors (HDs) (examination of the eligibility for BM transplantation) were obtained, among which circ_0000190 and miR-767-5p expressions were detected using reverse transcription quantitative polymerase chain reaction. In MM patients, Durie-Salmon stage and International Staging System (ISS) stage were assessed. Clinical responses (including complete response (CR) and objective response rate (ORR)) were assessed. The progression-free survival (PFS) and overall survival (OS) were calculated.

RESULTS

Circ_0000190 was decreased, but miR-767-5p was increased in MM patients compared with HDs. Circ_0000190 was negatively correlated with miR-767-5p in both HDs and MM patients. In MM patients, circ_0000190 was negatively correlated with ISS stage, serum creatinine, beta-2-microglobulin, and lactate dehydrogenase but was positively correlated with albumin. Whereas an opposite trend in miR-767-5p was observed. Regarding clinical response, circ_0000190 had the value for predicting increased ORR, while miR-767-5p had the value for predicting decreased CR and ORR. Circ_0000190 high expression was correlated with better PFS and OS, while miR-767-5p high expression was correlated with worse PFS and OS. Multivariate Cox's analyses revealed circ_0000190 high expression as an independent factor predicting better OS.

CONCLUSION

Circ_0000190 and its target miR-767-5p are dysregulated, and they are related to risk stratification and prognosis in MM patients.

摘要

背景

本研究旨在探讨环状 RNA_0000190(circ_0000190)与微小 RNA-767-5p(miR-767-5p)之间的相关性,及其与多发性骨髓瘤(MM)患者的生化指标、风险分层、治疗反应和生存之间的相关性。

方法

采集 86 例 MM 患者(在标准诊断过程中)和 30 例健康供者(HDs)(骨髓移植资格检查)的骨髓(BM)浆细胞,采用逆转录定量聚合酶链反应检测 circ_0000190 和 miR-767-5p 的表达。在 MM 患者中,评估 Durie-Salmon 分期和国际分期系统(ISS)分期。评估临床反应(包括完全缓解(CR)和客观缓解率(ORR))。计算无进展生存期(PFS)和总生存期(OS)。

结果

与 HDs 相比,MM 患者的 circ_0000190 降低,而 miR-767-5p 升高。circ_0000190 在 HDs 和 MM 患者中均与 miR-767-5p 呈负相关。在 MM 患者中,circ_0000190 与 ISS 分期、血清肌酐、β2-微球蛋白和乳酸脱氢酶呈负相关,与白蛋白呈正相关。而 miR-767-5p 则呈现相反的趋势。在临床反应方面,circ_0000190 有预测增加 ORR 的价值,而 miR-767-5p 有预测降低 CR 和 ORR 的价值。circ_0000190 高表达与更好的 PFS 和 OS 相关,而 miR-767-5p 高表达与更差的 PFS 和 OS 相关。多变量 Cox 分析显示 circ_0000190 高表达是预测 OS 更好的独立因素。

结论

circ_0000190 及其靶 miR-767-5p 失调,与 MM 患者的风险分层和预后相关。

相似文献

1
Circular RNA_0000190 and its target microRNA-767-5p are dysregulated, and they are related to risk stratification as well as prognosis in multiple myeloma patients.环状 RNA_0000190 及其靶 microRNA-767-5p 失调,与多发性骨髓瘤患者的风险分层及预后相关。
Ir J Med Sci. 2022 Apr;191(2):671-679. doi: 10.1007/s11845-021-02586-3. Epub 2021 Apr 16.
2
Circ-SMARCA5 suppresses progression of multiple myeloma by targeting miR-767-5p.环状 RNA-SMARCA5 通过靶向 miR-767-5p 抑制多发性骨髓瘤的进展。
BMC Cancer. 2019 Oct 10;19(1):937. doi: 10.1186/s12885-019-6088-0.
3
Long non-coding RNA ANRIL and its target microRNAs (microRNA-34a, microRNA-125a and microRNA-186) relate to risk stratification and prognosis in multiple myeloma.长链非编码 RNA ANRIL 及其靶 microRNAs(microRNA-34a、microRNA-125a 和 microRNA-186)与多发性骨髓瘤的风险分层和预后相关。
Hematology. 2021 Dec;26(1):160-169. doi: 10.1080/16078454.2021.1872275.
4
The Correlation of miR-671-5p with Diagnosis and Prognosis in Multiple Myeloma.miR-671-5p 与多发性骨髓瘤的诊断和预后的相关性。
Clin Lab. 2023 Aug 1;69(8). doi: 10.7754/Clin.Lab.2023.220826.
5
MicroRNA-146b overexpression associates with deteriorated clinical characteristics, increased International Staging System stage, cacoethic chromosome abnormality, and unfavorable prognosis in multiple myeloma patients.MicroRNA-146b 过表达与多发性骨髓瘤患者临床特征恶化、国际分期系统分期升高、核型不良及预后不良相关。
J Clin Lab Anal. 2020 May;34(5):e23168. doi: 10.1002/jcla.23168. Epub 2020 Jan 6.
6
Circ_SEC61A1 contributes to the progression of multiple myeloma cells via regulating miR-660-5p/CDK6 axis.环状 RNA SEC61A1 通过调控 miR-660-5p/CDK6 轴促进多发性骨髓瘤细胞的进展。
Leuk Res. 2022 Feb;113:106774. doi: 10.1016/j.leukres.2021.106774. Epub 2021 Dec 31.
7
Dysregulated circular RNAs are closely linked to multiple myeloma prognosis, with circ_0026652 predicting bortezomib‑based treatment response and survival via the microRNA‑608‑mediated Wnt/β‑catenin pathway.失调的环状 RNA 与多发性骨髓瘤的预后密切相关,circ_0026652 通过 microRNA-608 介导的 Wnt/β-catenin 通路预测硼替佐米为基础的治疗反应和生存。
Oncol Rep. 2022 Nov;48(5). doi: 10.3892/or.2022.8410. Epub 2022 Sep 21.
8
Circular RNA_0003489 reflects unfavorable treatment response and shortened survival in newly diagnosed multiple myeloma patients who receive bortezomib-based induction therapy.环状 RNA_0003489 反映了接受硼替佐米为基础的诱导治疗的新诊断多发性骨髓瘤患者的不良治疗反应和生存时间缩短。
Hematology. 2024 Dec;29(1):2399419. doi: 10.1080/16078454.2024.2399419. Epub 2024 Sep 13.
9
Circ-MTO1 correlates with favorable prognosis and inhibits cell proliferation, invasion as well as miR-17-5p expression in prostate cancer.环状 RNA-MTO1 与前列腺癌的良好预后相关,并抑制细胞增殖、侵袭以及 miR-17-5p 的表达。
J Clin Lab Anal. 2020 Mar;34(3):e23086. doi: 10.1002/jcla.23086. Epub 2019 Nov 11.
10
Long non-coding RNA NEAT1 serves as a novel biomarker for treatment response and survival profiles via microRNA-125a in multiple myeloma.长链非编码 RNA NEAT1 作为一种新型生物标志物,通过 microRNA-125a 在多发性骨髓瘤中预测治疗反应和生存情况。
J Clin Lab Anal. 2020 Sep;34(9):e23399. doi: 10.1002/jcla.23399. Epub 2020 Jul 1.

引用本文的文献

1
Circular RNA as Diagnostic and Prognostic Biomarkers in Hematological Malignancies:Systematic Review.环状 RNA 作为血液系统恶性肿瘤的诊断和预后生物标志物的系统评价。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241285149. doi: 10.1177/15330338241285149.
2
Recent Progress of CircRNAs in Hematological Malignancies.环状 RNA 在血液系统恶性肿瘤中的最新研究进展。
Int J Med Sci. 2024 Sep 30;21(13):2544-2561. doi: 10.7150/ijms.98156. eCollection 2024.
3
N6-methyladenosine-modified circ_0000337 sustains bortezomib resistance in multiple myeloma by regulating DNA repair.
N6-甲基腺嘌呤修饰的circ_0000337通过调节DNA修复维持多发性骨髓瘤对硼替佐米的耐药性。
Front Cell Dev Biol. 2024 Mar 22;12:1383232. doi: 10.3389/fcell.2024.1383232. eCollection 2024.
4
CircRNAs in diagnosis, prognosis, and clinicopathological features of multiple myeloma; a systematic review and meta-analysis.环状RNA在多发性骨髓瘤诊断、预后及临床病理特征中的作用;一项系统综述和荟萃分析
Cancer Cell Int. 2023 Aug 26;23(1):178. doi: 10.1186/s12935-023-03028-z.
5
Comprehensive elaboration of circular RNA in multiple myeloma.多发性骨髓瘤中环状RNA的全面阐述
Front Pharmacol. 2022 Aug 29;13:971070. doi: 10.3389/fphar.2022.971070. eCollection 2022.
6
Overexpression of circ PTK2 suppresses the progression of nonalcoholic fatty liver disease via the miR-200c/SIK2/PI3K/Akt axis.circPTK2 的过表达通过 miR-200c/SIK2/PI3K/Akt 轴抑制非酒精性脂肪性肝病的进展。
Kaohsiung J Med Sci. 2022 Sep;38(9):869-878. doi: 10.1002/kjm2.12568. Epub 2022 Jul 6.
7
CircRNAs: novel therapeutic targets in multiple myeloma.环状 RNA:多发性骨髓瘤的新型治疗靶点。
Mol Biol Rep. 2022 Nov;49(11):10667-10676. doi: 10.1007/s11033-022-07668-8. Epub 2022 Jun 21.
8
Circular RNA as a Novel Biomarker for Diagnosis and Prognosis and Potential Therapeutic Targets in Multiple Myeloma.环状RNA作为多发性骨髓瘤诊断、预后的新型生物标志物及潜在治疗靶点
Cancers (Basel). 2022 Mar 27;14(7):1700. doi: 10.3390/cancers14071700.